You have 9 free searches left this month | for more free features.

Ivacaftor

Showing 1 - 25 of 197

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
May 19, 2023

Elexacaftor/Tezacaftor/Ivacaftor, in Cystic Fibrosis and Caloric

Completed
  • Cystic Fibrosis
  • nutritional intake questionnaire
  • Bordeaux, France
  • +2 more
Oct 2, 2023

Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor

Enrolling by invitation
  • Cystic Fibrosis
    • Denver, Colorado
    • +1 more
    Apr 7, 2023

    CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -

    Recruiting
    • Cystic Fibrosis
    • Elexacaftor / Ivacaftor / Tezacaftor
    • Erlangen, Bavaria, Germany
      University Hospital Erlange, Department of Pediatrics
    Oct 7, 2022

    Cystic Fibrosis (CF), CFTR Gene Mutation Trial (12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause)

    Not yet recruiting
    • Cystic Fibrosis (CF)
    • CFTR Gene Mutation
    • 12 hours ETI pause
    • +2 more
    • (no location specified)
    Apr 17, 2023

    Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet

    Not yet recruiting
    • Healthy Volunteer
    • Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
    • Lumacaftor 200 mg Film-Coated Tablet Formulation
    • (no location specified)
    Jul 21, 2023

    Ivacaftor for Acquired CFTR Dysfunction in Chronic

    Active, not recruiting
    • CRS
    • EDSPD
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 24, 2022

    Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

    Completed
    • Cystic Fibrosis
    • Chermside, Australia
    • +23 more
    Jan 17, 2023

    Cystic Fibrosis Trial (ELX/TEZ/IVA, IVA)

    Recruiting
    • Cystic Fibrosis
    • Gent, Belgium
    • +18 more
    Feb 2, 2023

    Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects

    Completed
    • Cystic Fibrosis
    • Ivacaftor
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 10, 2022

    Cystic Fibrosis Trial in Worldwide (ivacaftor)

    Active, not recruiting
    • Cystic Fibrosis
    • ivacaftor
    • Birmingham, Alabama
    • +22 more
    Feb 4, 2022

    Cystic Fibrosis Trial in Worldwide (Ivacaftor)

    Active, not recruiting
    • Cystic Fibrosis
    • Ivacaftor
    • Birmingham, Alabama
    • +28 more
    Sep 14, 2022

    Drug Drug Interaction Trial in Los Angeles (Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg], Rifabutin

    Recruiting
    • Drug Drug Interaction
    • Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
    • Rifabutin 300mg
    • Los Angeles, California
      University of Southern California
    May 9, 2022

    Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor

    Completed
    • Cystic Fibrosis
    • Paris, France
      Adult CF center, Service de Pneumologie, Cochin Hospital
    Dec 20, 2021

    COPD, Chronic Bronchitis Trial in Birmingham (Ivacaftor 150 MG, Placebo)

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • Chronic Bronchitis
    • Ivacaftor 150 MG
    • Placebo
    • Birmingham, Alabama
      UAB Lung Health Center
    Mar 24, 2022

    Respiratory Symptoms and Spirometry During ETI Treatment in

    Active, not recruiting
    • Cystic Fibrosis
    • Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening
    • Liège, Belgium
      Lebecque
    Oct 25, 2022

    Cystic Fibrosis Trial in France (Sample collection)

    Recruiting
    • Cystic Fibrosis
    • Sample collection
    • Bordeaux, France
    • +14 more
    Jul 7, 2023

    Cystic Fibrosis Transmembrane Regulator Biomarker Study to

    Recruiting
    • Cystic Fibrosis
    • Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor
    • Berlin, Germany
    • +3 more
    Apr 1, 2022

    : TRANSITION: An Observational Study of Transition From

    Completed
    • Cystic Fibrosis (CF)
      • Denver, Colorado
        National Jewish Heatlh
      Sep 3, 2021

      Chronic Bronchitis Trial in Birmingham (Ivacaftor (VX-770))

      Withdrawn
      • Chronic Bronchitis
      • Ivacaftor (VX-770)
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Feb 1, 2022

      Trikafta Exercise Study in Cystic Fibrosis

      Recruiting
      • Cystic Fibrosis
      • Lung Diseases
      • Vancouver, British Columbia, Canada
        UBC Centre for Heart Lung Innovation, St. Paul's Hospital
      Mar 3, 2022

      COPD Trial (Ivacaftor)

      Withdrawn
      • Chronic Obstructive Pulmonary Disease
      • Ivacaftor
      • (no location specified)
      Jan 11, 2022

      Cystic Fibrosis Trial in Germany (LUM, LUM/IVA, IVA)

      Completed
      • Cystic Fibrosis
      • Berlin, Germany
      • +4 more
      Nov 8, 2021

      Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

      Completed
      • Cystic Fibrosis
      • Adelaide, Australia
      • +18 more
      Aug 24, 2022

      Cystic Fibrosis Trial in Birmingham (Symdeko)

      Recruiting
      • Cystic Fibrosis
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 30, 2022